The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

Elias Zerhouni listens to the gripes at his third town hall meeting with employees since becoming director of the National Institutes of Health nearly two years ago. The Bethesda, Md., campus lacks ...

Dr. Zerhouni is director of the National Institutes of Health. Rachel Gotbaum, the interviewer, is an independent producer based in Boston.

Phillip Frost; Chairman of the Board, Chief Executive Officer; OPKO Health Inc Elias Zerhouni; President, Vice Chairman of the Board; OPKO Health Inc Good day. And welcome to the OPKO Health fourth ...

That began to change in 2008, after NIH Director Elias Zerhouni issued the goal to “Fund the best science, by the best scientists…” 1 As a result, new guidelines, requirements, and considerations have ...

Operator Good day, and welcome to the OPKO Health fourth quarter 2024 financial results conference call. All participants will be in a listen-only mode. [Operator instructions] After today's ...

Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisors IRDr.